{"schema_version":"secwatch.filing_event.v1","accession":"0001200375-22-000026","form_type":"8-K","ticker":"CDXS","cik":"0001200375","company_name":"CODEXIS, INC.","filed_at":"2022-07-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.151411+00:00","generated_at":"2026-06-24T14:48:38.523956+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Codexis signs 10-year supply deal with Pfizer for PAXLOVID enzyme CDX-616; receives $25.9M retainer","bullets":["Supply Agreement covers Codexis enzyme CDX-616 used in Pfizer's PAXLOVID (nirmatrelvir).","Pfizer pays $25.9M retainer fee by July 31, 2022; up to 90% creditable against future orders through 2023.","Revenue recognition: nominal portion in 2022, remainder in 2023-2024.","No minimum purchase commitments; Codexis must maintain sufficient inventory for estimated Pfizer orders.","Pfizer may terminate on 180 days' notice; term of 10 years with 3-year renewal options."],"urls":{"canonical":"https://secwatch.observer/filing/0001200375-22-000026","json":"https://secwatch.observer/filing/0001200375-22-000026.json","markdown":"https://secwatch.observer/filing/0001200375-22-000026.md","text":"https://secwatch.observer/filing/0001200375-22-000026.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1200375/000120037522000026/0001200375-22-000026-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1200375/000120037522000026/cdxs-20220714.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T14:48:38.523956+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}